EXTON, Pa., Aug. 23, 2018 /PRNewswire/ -- West
Pharmaceutical Services, Inc. (NYSE: WST), a global leader in
innovative solutions for injectable drug administration, today
announced that its Management Team will present an overview of the
Company's business at three investor conferences in September.
Management will present at the Baird 2018 Global Healthcare
Conference in New York, New York
at 2:35 p.m. EDT on Wednesday, September 5,
2018; the Morgan Stanley 16th Annual Global Healthcare
Conference in New York, New York
at 12:20 p.m. EDT on Thursday, September 13,
2018; and at the Janney Montgomery Scott Healthcare
Conference in New York, New York
at 9:05 a.m. EDT on Tuesday, September 18,
2018.
A live audio webcast and accompanying slides of each of the
presentations will be accessible from the Company's website at
www.westpharma.com/en/investors.
About West
West Pharmaceutical Services, Inc. is a
leading manufacturer of packaging components and delivery systems
for injectable drugs and healthcare products. Working by the side
of its customers from concept to patient, West creates products
that promote the efficiency, reliability and safety of the world's
pharmaceutical drug supply. West is headquartered in Exton, Pennsylvania, and supports its
customers from locations in North and South America, Europe, Asia
and Australia. West's 2017 net
sales of $1.6 billion reflect the
daily use of approximately 112 million of its components and
devices, which are designed to improve the delivery of healthcare
to patients around the world.
Trademarks and registered trademarks are the property of West
Pharmaceutical Services, Inc. in the
United States and other jurisdictions, unless noted
otherwise.
Investor
Contact:
|
Media
Contact:
|
Quintin Lai
|
Emily
Denney
|
Vice President,
Investor Relations
|
Vice President,
Global Communications
|
+1-610-594-3318
|
+1-610-594-3035
|
Quintin.Lai@westpharma.com
|
Emily.Denney@westpharma.com
|
View original content with
multimedia:http://www.prnewswire.com/news-releases/west-announces-participation-in-upcoming-september-investor-conferences-300701047.html
SOURCE West Pharmaceutical Services, Inc.